Evidence map›Paper›PMID 31622116›Full record

ArticlePharmaceutical biology2019

Lanzhou Li, Di Wang, Xueju Wang, Ruifeng Bai, Chunyu Wang, Yin Gao, Tassos Anastassiades

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The Evolving Landscape of Gout in the Female: A Narrative Review.Gout, urate, and crystal deposition disease · 2023
    Article
  5. Article
  6. Article
  7. Molecules (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lanzhou LiKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University , Changchun , China.
Di WangKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University , Changchun , China.
Xueju WangPathology Department of China-Japan Union Hospital, Jilin University , Changchun , China.
Ruifeng BaiKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University , Changchun , China.
Chunyu WangState Key Laboratory of Supramolecular Structure and Materials, Jilin University , Changchun , China.
Yin GaoKey Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University , Changchun , China.ORCID http://orcid.org/0000-0002-0763-0254
Tassos AnastassiadesDivision of Rheumatology, Department of Medicine, Queen's University , Kingston , Canada.ORCID http://orcid.org/0000-0002-5805-0364
Jilin University · CNQueen's University · CAUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsArthritis, GoutyButyratesDisease Models, AnimalDose-Response Relationship, DrugHyaluronic AcidHyperuricemiaInflammationMaleMiceMice, Inbred BALB CRatsRats, WistarUric AcidAnti-Inflammatory AgentsAntioxidantsButyratesHyaluronic AcidUric Acid-acylationCytokinesROS

Identifiers

PMID31622116
PMCPMC8871623
OpenAlexW2981203273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.